Mepolizumab

Red

Brand Name(s):Nucala

Indication:Asthma

Rationale:1,2

Considered:Jan-16

Review Date:Feb-22

Comments:
NICE TA431
Mepolizumab for treating severe refractory eosinophilic asthma
Jan-17